PROCEPT BioRobotics (PRCT) Capital Expenditures (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Capital Expenditures data on file, last reported at $2.9 million in Q1 2026.

• On a quarterly basis, Capital Expenditures rose 109.94% year-over-year to $2.9 million in Q1 2026; TTM through Mar 2026 was $10.9 million, a 824.55% increase from a year earlier, with the FY2025 full-year figure at $9.4 million, up 2588.51% from the prior year.
• Capital Expenditures for Q1 2026 stood at $2.9 million, up from $1.8 million in the prior quarter.
• Over the last five years, Capital Expenditures for PRCT reached as high as $5.8 million in Q3 2023 and fell as low as -$14.6 million in Q4 2023.
• Historically, Capital Expenditures has averaged $1.1 million across 5 years, with a median of $1.8 million in 2022.
• On a YoY basis, Capital Expenditures climbed as much as 6987.18% in 2023 and fell as far as 932.56% in 2023.
• Year by year, Capital Expenditures stood at $1.8 million in 2022, then sank by 932.56% to -$14.6 million in 2023, then soared by 102.21% to $323000.0 in 2024, then soared by 472.76% to $1.8 million in 2025, then soared by 57.51% to $2.9 million in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $2.9 million in Q1 2026, $1.8 million in Q4 2025, and $2.9 million in Q3 2025.